OCULOMED
ActiveOCULOMED has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.29M and a net result of €65k. Equity is growing by ~7.7% per year across the filed fiscal years. Its solvency ranks better than 67% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability63▲+17
Solvency100▲+6
Growth42=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 1.78 against 1.38 in 2024; short-term debt: 19.7% and cash: 10.2% of total assets), and 21.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
78.7%
Return on assets
4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-08-2026, 4 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
4 d late
2024
6 d late
2023
12 d late
2022
58 d late
2021
19 d late
2020
4 d late
2019
38 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€372k▼ 3.4%
2018 · €385k
2018: €385k
2018 → 2019
EBIT margin
36.6%▼ 2.7pp
2018 · 39.3%
2018: 39.3%
2018 → 2019
Net result
€65k▲ 50.7%
2024 · €43k
2018: €100k
2019: €78k
2020: €39k
2021: €53k
2022: €363k
2023: €72k
2024: €43k
2018 → 2025
Working capital
€253k▲ 32.7%
2024 · €191k
2018: €-272k
2019: €-241k
2020: €-396k
2021: €-97k
2022: €12k
2023: €112k
2024: €191k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€749k-€1.11M▲ 48.4%€1.18M▲ 6.5%€1.23M▲ 3.7%€1.29M▲ 5.3%
Operating result€99k-€426k▲ 332%€129k▼ 69.6%€103k▼ 20.3%€125k▲ 20.8%
Net result€53k-€363k▲ 585%€72k▼ 80.2%€43k▼ 39.6%€65k▲ 50.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 21% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.64M
Fixed assets
€1.07M▼ 0.8%
Current assets
€577k▼ 16.6%
Equity and liabilities €1.64M
Equity
€1.29M▲ 5.3%
Debt
€351k▼ 35.0%
The debt ratio falls from 30.5% to 21.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€133k▲
2024 · €116k
Cash flow
€74k▲
2024 · €56k
Solvency
78.7%▲
2024 · 69.5%
Current ratio
1.78▲
2024 · 1.38
Quick ratio
1.78▲
2024 · 1.38
Debt / equity
0.27▼
2024 · 0.44
ROE
5.1%▲
2024 · 3.5%
ROA
4.0%▲
2024 · 2.5%
Interest coverage
4.68▲
2024 · 2.96
Debt
€351k▼
2024 · €540k
Debt ≤ 1 year
€323k▼
2024 · €501k
Income taxes
€31k▲
2024 · €21k
Staff costs
€60k▼
2024 · €62k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.77M€1.64M▼
Fixed assets21/28€1.08M€1.07M▼
Tangible fixed assets22/27€25k€17k▼
Plant, machinery and equipment23€9k€6k▼
Furniture and vehicles24€4k€722▼
Other tangible fixed assets26€12k€10k▼
Financial fixed assets28€1.05M€1.05M=
Current assets29/58€692k€577k▼
Amounts receivable within one year40/41€145k€17k▼
Trade receivables40€20k€2k▼
Other amounts receivable41€125k€15k▼
Current investments50/53€389k€389k=
Cash at bank and in hand54/58€155k€167k▲
Deferred charges and accrued income490/1€3k€4k▲
Equity and liabilities
Total equity and liabilities10/49€1.77M€1.64M▼
Equity10/15€1.23M€1.29M▲
Contributions10/11€186k€186k=
Reserves13€1.04M€1.11M▲
Non-distributable reserves130/1€19k-
Reserves not available under the articles1311€19k-
Distributable reserves133€1.02M€1.11M▲
Amounts payable17/49€540k€351k▼
Amounts payable within one year42/48€501k€323k▼
Trade debts44€5k€6k▲
Suppliers440/4€5k€6k▲
Taxes, remuneration and social security45€20k€18k▼
Taxes450/3€12k€11k▼
Remuneration and social security454/9€8k€7k▼
Other amounts payable47/48€476k€299k▼
Accrued charges and deferred income492/3€39k€28k▼
Income statement
Code20242025
Remuneration, social security and pensions62€62k€60k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€9k▼
Other operating charges640/8-€159
Gross operating margin9900€177k€193k▲
Operating profit (loss)9901€103k€125k▲
Financial income75/76B€0€47▲
Recurring financial income75€0€47▲
Financial charges65/66B€39k€28k▼
Recurring financial charges65€39k€28k▼
Profit (loss) for the period before taxes9903€64k€96k▲
Income taxes67/77€21k€31k▲
Profit (loss) for the period9904€43k€65k▲
Profit (loss) for the period to be appropriated9905€43k€65k▲
Appropriation of the result
Profit (loss) to be appropriated9906€43k€65k▲
Transfer to equity691/2€43k€65k▲
To other reserves6921€43k€65k▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 4 days late
2025
06-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 6 days late
2024
12-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 12 days late
2023
27-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 58 days late
2022
31-12
Financial
Highest result since 2018net €363k ▲585%
Operating result €426k, net result €363k, both a record.
31-12
Financial
Equity above €1MEq €1.11M ▲48.4%
5 profitable years in a row build equity to €1.11M.
19-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 19 days late
2021
04-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 4 days late
2020
31-12
Financial
Weakest financial yearnet €39k ▼49.6%
Net result drops to €39k, the lowest in the series; recovery starts the following year.
07-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 38 days late
2019
02-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
31-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
28-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Enghien · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Aatsesteenweg 207850 EnghienGround area
963 m²
Building footprint
142 m²
Parcel 55025A0532/00S000, Wallonia. Linked by address, not a title deed.
1 establishment unit
OCULOMED
since 20082.171.688.062
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 55025A0532/00S000 | Wallonia | 963 m² | 1 · 142 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
9676004RSZARR0H40G18
Similar companies · same sector, comparable size
OROTRACT
BE 0466.746.875
Namur · Eq €1.29M
DR A DE GEYNDT
BE 0895.059.283
Brasschaat · Eq €1.29M
DR. A. LAUWERS-ANESTHESIST
BE 0501.575.617
Bonheiden · Eq €1.29M
CARDIOLOGIE GILLES DE KEULENAER
BE 0883.576.265
Boechout · Eq €1.29M
RADIOLOGIE DR. PEERSMAN
BE 0478.904.737
Leuven · Eq €1.29M
Of 16,628 companies in sector 86220 we hold annual accounts for 7,974. 5,409 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-05-2008
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.